| Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond | Statistics in Medicine | 2008 | 4.5K |
| General cardiovascular risk profile for use in primary care: the Framingham Heart Study | Circulation | 2008 | 4.3K |
| Assessing the performance of prediction models: a framework for traditional and novel measures | Epidemiology | 2010 | 2.5K |
| Metabolite profiles and the risk of developing diabetes | Nature Medicine | 2011 | 2K |
| Vitamin D deficiency and risk of cardiovascular disease | Circulation | 2008 | 1.8K |
| Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers | Statistics in Medicine | 2011 | 1.6K |
| Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation | JAMA - Journal of the American Medical Association | 2001 | 1.4K |
| Comments on ‘Integrated discrimination and net reclassification improvements—Practical advice’ | Statistics in Medicine | 2008 | 1.2K |
| Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation | Statistics in Medicine | 2004 | 1.1K |
| Genome-wide association study of blood pressure and hypertension | Nature Genetics | 2009 | 1.1K |
| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial | Lancet, The | 2018 | 771 |
| A Suggestion for Using Powerful and Informative Tests of Normality | American Statistician | 1990 | 720 |
| 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study | Lancet, The | 2015 | 714 |
| On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data | Statistics in Medicine | 2011 | 672 |
| Measuring phase-amplitude coupling between neuronal oscillations of different frequencies | Journal of Neurophysiology | 2010 | 668 |
| Rare independent mutations in renal salt handling genes contribute to blood pressure variation | Nature Genetics | 2008 | 639 |
| The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination | American Journal of Epidemiology | 2007 | 605 |
| Predicting the 30-year risk of cardiovascular disease: the framingham heart study | Circulation | 2009 | 553 |
| Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study | Circulation | 2008 | 540 |
| Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study | International Journal of Obesity | 2003 | 485 |
| Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute | Circulation | 2009 | 475 |
| Electroencephalogram signatures of loss and recovery of consciousness from propofol | Proceedings of the National Academy of Sciences of the United States of America | 2013 | 444 |
| A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization | Nature Genetics | 2006 | 438 |
| Parental transmission of type 2 diabetes: the Framingham Offspring Study | Diabetes | 2000 | 424 |
| Mistranslation of membrane proteins and two-component system activation trigger antibiotic-mediated cell death | Cell | 2008 | 388 |
